Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

William Clay Faquin, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by William Faquin and Paul Vanderlaan.
Connection Strength

0.126
  1. Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries. Cancer Cytopathol. 2020 Dec; 128(12):885-894.
    View in: PubMed
    Score: 0.059
  2. Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy. Laryngoscope. 2014 Jan; 124(1):188-195.
    View in: PubMed
    Score: 0.035
  3. The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio: a proposed performance measure for reporting in The Bethesda System for thyroid cytopathology. Cancer Cytopathol. 2012 Apr 25; 120(2):111-6.
    View in: PubMed
    Score: 0.031
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.